RFI released for a new institute of substance use and addiction disorders
On February 8, the National Institutes of Health released a Request for Information (RFI) to receive input on the strategic plan for the proposed National Institute of Substance Use and Addiction Disorders. APA along with our partner organizations advocated (PDF, 194KB) repeatedly for this opportunity and it is our hope that the extramural science community will rally with a vigorous response. The latest strategic plans for the individual institutes were completed in 2009 and 2010 for NIAAA and NIDA respectively. At the NIAAA Advisory Council meeting on February 9, Dr. George Kunos, Scientific Director of NIAAA’s Intramural Research Program, indicated that a functional integration with NIDA’s Intramural Research Program was already well underway in three key areas: a joint clinical research program, genetic studies of substance use disorders and medicinal chemistry.
In addition, NIDA and several other Institutes are actively collaborating with the Food and Drug Administration’s Center for Tobacco Products, which is funding a range of research (PDF, 1.4MB) needed to inform regulatory decisions FDA will make as it fulfills the statutory requirements of the Family Smoking Prevention and Tobacco Control Act. That research agenda is rapidly taking shape and is the topic of an FDA sponsored workshop (PDF, 142KB) on this last day in February, where several APA members are presenting on the topic of challenges to conducting research.